prednisone has been researched along with levodopa in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (26.67) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jolivette, LJ; Ward, KW | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Asboe-Hansen, G | 2 |
| Ben-David, MM; Brautbar, NN | 1 |
| Roszkowski, AP; Schuler, ME | 1 |
| Carmenini, G; Di Maio, F; Martusciello, S; Meloni, F; Nicoletti, M; Scioli, A | 1 |
| Alagia, G; Bellomo, G; Ciuffetti, G; Mercuri, M; Santambrogio, L | 1 |
| Ansari, AA; Breeze, RE; Freed, CR; Hutchinson, M; Kriek, EH; Mayne, A; Mazziotta, JC; O'Brien, CF; Schneck, SA; Zhang, YB | 1 |
| Alm, M; Emnéus, J; Ghani, M; Heiskanen, A; Kajtez, J; Kristensen, A; Larsen, NB; Rezaei, B; Thomsen, P; Žukauskas, A | 1 |
1 trial(s) available for prednisone and levodopa
| Article | Year |
|---|---|
Lack of a detectable systemic humoral/cellular allogeneic response in human and nonhuman primate recipients of embryonic mesencephalic allografts for the therapy of Parkinson's disease.
Topics: Animals; Antibody Formation; Antibody-Dependent Cell Cytotoxicity; Brain Tissue Transplantation; Cell Line; Cyclosporine; Cytotoxicity, Immunologic; Fetal Tissue Transplantation; Follow-Up Studies; Humans; Immunity, Cellular; Levodopa; Lymph Nodes; Mesencephalon; Parkinson Disease; Prednisone; Primates; Spleen; T-Lymphocytes, Cytotoxic; Time Factors; Transplantation, Homologous | 1995 |
14 other study(ies) available for prednisone and levodopa
| Article | Year |
|---|---|
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Treatment of generalized scleroderma: updated results.
Topics: Chlorpromazine; Collagen; Drug Evaluation; Glutamine; Glycosaminoglycans; Humans; Hydralazine; Levodopa; Penicillamine; Penicillin G; Phenytoin; Prednisone; Scleroderma, Systemic | 1979 |
Adrenogenital syndrome (11-beta-hydroxylase deficiency) with hyperprolactinemia: reversal by glucocorticoid administration.
Topics: Adolescent; Adrenal Hyperplasia, Congenital; Humans; Levodopa; Male; Prednisone; Prolactin; Steroid Hydroxylases; Thyrotropin-Releasing Hormone | 1977 |
Effects of corticoids on experimentally induced depression.
Topics: Adrenal Cortex Hormones; Animals; Antidepressive Agents; Body Temperature; Corticosterone; Fever; Hydrocortisone; Levodopa; Male; Mice; Pargyline; Prednisone; Reserpine; Time Factors | 1975 |
[Horton's bitemporal arteritis. A case report].
Topics: Aged; Biopsy; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Levodopa; Prednisone; Ranitidine; Syndrome; Temporal Arteries | 1992 |
Temporal arteritis presenting as an extrapyramidal disorder.
Topics: Aged; Arteritis; Cerebral Arterial Diseases; Diagnosis, Differential; Female; Humans; Levodopa; Parkinson Disease; Prednisone | 1990 |
Treatment of generalized scleroderma with inhibitors of collagen synthesis.
Topics: Catechin; Chlorpromazine; Collagen; Dextrothyroxine; Glutamine; Humans; Hydralazine; Levodopa; Penicillamine; Penicillin G; Phenytoin; Prednisone; Scleroderma, Systemic | 1982 |
On-Demand Reversible UV-Triggered Interpenetrating Polymer Network-Based Drug Delivery System Using the Spiropyran-Merocyanine Hydrophobicity Switch.
Topics: Anti-Inflammatory Agents; Benzopyrans; Delayed-Action Preparations; Dopamine; Dopamine Agents; Drug Delivery Systems; Drug Liberation; Hydrophobic and Hydrophilic Interactions; Indoles; Levodopa; Nitro Compounds; Polymers; Prednisone; Ultraviolet Rays | 2021 |